Apoptosis in the human female reproductive tract

Obstetrical and Gynecological Survey

Volumn 51, Issue 5, 1996, Pages 314-323

  Spencer, Susan J ^a   Cataldo, Nicholas A ^a   Jaffe, Robert B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; MIFEPRISTONE; ONCOPROTEIN; PROTEIN P53;

APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CARCINOGENESIS; CELL CYCLE; CELL DEATH; ENDOMETRIUM; FEMALE GENITAL SYSTEM; GENE EXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; OVARY DEVELOPMENT; PROGNOSIS; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

ADULT; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL CYCLE; ENDOMETRIUM; FEMALE; HUMANS; OVARY;

EID: 0029980653     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199605000-00023     Document Type: Review

References (103)

1. Kerr J, Wyllie A, Currie A. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239.
2. Cordon-Cardo C. Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-560.
3. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-1449.
4. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
5. Wyllie A. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 1980; 284:555-556.
6. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992;80:879-886.
7. Hockenbery D. BCL-2 in cancer, development and apoptosis. J Cell Sci 1994;18:51-55.
8. Lu Q, Poulsom R, Wong L et al. Bcl-2 expression in adult and embryonic nonhematopoietic tissues. J Pathol 1993;169: 431-437.
9. Otsuki Y, Misaki O, Sugimoto O et al. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 1994;344:28-29.
10. Oltvai Z, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
11. Korsmeyer S, Shutter J, Veis D et al. Bcl-2/Bax: A rheostat that regulates an antioxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332.
12. Boise LH, González-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
13. Bargou R, Bommert K, Weinmann P et al. Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: Potential role of the bcl-2 gene family in surface IgM-mediated apoptosis. Eur J Immunol 1995;25:770-775.
14. Selvakumaran M, Lin H-K, Miyashita T et al. Immediate early up-regulation of bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways. Oncogene 1994; 9:1791-1798.
15. Miyashita T, Krajewski S, Krajewska M et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
16. Chiou S, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994;14:2556-2563.
17. Metz T, Harris A, Adams J. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 1995;82:29-36.
18. Elledge R, Allred D. The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat 1994;32:39-47.
19. Himelstein-Braw R, Byskov AG, Peters H et al. Follicular atresia in the infant human ovary. J Reprod Fertil 1976;46: 55-59.
20. Block E. Quantitative morphological investigations of the follicular system in women. Variations at different ages. Acta Anat 1952;14:108-123.
21. Koopman P, Gubbay J, Vivian N et al. Male development of chromosomally female mice transgenic for Sry. Nature 1991; 351:117-121.
22. Bardoni B, Zanaria E, Guioli S et al. A dosage sensitive locus at Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501.
23. Coucouvanis EC, Sherwood SW, Carswell-Crumpton C et al. Evidence that the mechanism of prenatal germ cell death in the mouse is apoptosis. Exp Cell Res 1993;209:238-247.
24. Manova K, Nocka K, Besmer P et al. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 1990;110:1057-69.
25. Matsui Y, Zsebo KM, Hogan BLM. Embryonic expression of a hematopoietic growth factor encoded by the SI locus and the ligand for c-kit. Nature 1990;347:667-669.
26. Huang EJ, Manova K, Packer AI et al. The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Dev Biol 1993;157:100-109.
27. Bedell MA, Brannan CI, Evans EP et al. DNA rearrangements located over 100 kb 5′ of the Steel (SI)-coding region in Steel-panda and Steel-contrasted mice deregulate SI expression and cause female sterility by disrupting ovarian follicle development. Genes Dev 1995;9:455-470.
28. Pesce M, Farrace MG, Piacentini M et al. Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 1993;118:1089-1094.
29. Cheng L, Gearing DP, White LS et al. Role of leukemia inhibitory factor and its receptor in mouse primordial germ cell growth. Development 1994;120:3145-3153.
30. Gougeon A. Dynamics of follicular growth in the human: A model from preliminary results. Hum Reprod 1986;1:81-87.
31. Bomsel-Helmreich O, Gougeon A, Thebault A et al. Healthy and atretic human follicles in the preovulatory phase: Differences in evolution of follicular morphology and steroid content of follicular fluid. J Clin Endocrinol Metab 1979;48:686-694.
32. -+-dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology 1989;125:2218-2220.
33. Tilly JL, Kowalski KI, Johnson AL et al. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991;129:2799-2801.
34. Hughes FM Jr, Gorospe WC. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: Evidence for a potential mechanism underlying follicular atresia. Endocrinology 1991;129:2415-2422.
35. Tilly JL, Kowalski KI, Schomberg DW et al. Apoptosis in atretic ovarian follicles is associated with selective decreases in messenger ribonucleic acid transcripts for gonadotropin receptors and cytochrome P450 aromatase. Endocrinology 1992;131:1670-1676.
36. Tilly JL. Ovarian follicular atresia: A model to study the mechanisms of physiological cell death. Endocr J 1993;1:67-72.
37. Palumbo A, Yeh J. In situ localization of apoptosis in the rat ovary during follicular atresia. Biol Reprod 1994;51:888-895.
38. Jolly PD, Tisdall DJ, Heath DA et al. Apoptosis in bovine granulosa cells in relation to steroid synthesis, cyclic adenosine 3′,5′-monophosphate response to follicle-stimulating hormone and luteinizing hormone, and follicular atresia. Biol Reprod 1994;51:934-944.
39. Tilly JL, Billig H, Kowalski KI et al. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 1992;6:1942-1950.
40. Chun S-Y, Billig H, Tilly JL et al. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: Mediatory role of endogenous insulin-like growth factor I. Endocrinology 1994;135:1845-1853.
41. Billig H, Furuta I, Hsueh AJW. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1993;133:2204-2212.
42. Billig H, Furuta I, Hsueh AJW. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology 1994;134: 245-252.
43. Eisenhauer KM, Chun S-Y, Billig H et al. Growth hormone suppression of apoptosis in preovulatory rat follicles and partial neutralization by insulin-like growth factor binding protein. Biol Reprod 1995;53:13-20.
44. Chun S-Y, Eisenhauer KM, Kubo M et al. Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 1995;136:3120-3127.
45. Stouffer RL, Woodruff TK, Dahl KD et al. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys. J Clin Endocrinol Metab 1993;77:241-248.
46. Miró F, Hillier SG. Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J Clin Endocrinol Metab 1992;75:1556-1561.
47. Brannian JD, Woodruff TK, Mather JP et al. Activin-A inhibits progesterone production by macaque luteal cells in culture. J CNn Endocrinol Metab 1992;75:756-761.
48. Rabinovici J, Spencer S, Doldi N et al. Activin-A as an intraovarian modulator: Actions, localization, and regulation of the intact dimer in human ovarian cells. J Clin Invest 1992; 89:1528-1536.
49. Eguchi Y, Ewert DL, Tsujimoto Y. Isolation and characterization of the chicken bcl-2 gene: Expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res 1992;20:4187-4192.
50. Tilly JL, Tilly KI, Kenton ML et al. Expression of members of the Bcl-2 gene family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-x-long messenger ribonucleic acid levels. Endocrinology 1995;136:232-241.
51. Lee BS, Robinson RD, Best CL et al. Expression of apoptosis related genes, Bcl-2 and TRPM-2, in human luteinized granulosa cells (abstr). J Soc Gynecol Invest 1995;2:389.
52. Schomberg DW, Tilly KI, Tilly JL. Apoptosis in ovarian cells: Studies in vivo and in vitro of porcine granulosa cell Bax gene expression. The Endocrine Society 77th Annual Meeting, Abstract 149, 1995.
53. Tilly KI, Banerjee S, Banerjee PP et al. Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: Gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles. Endocrinology 1995;136:1394-1402.
54. Oehm A, Behrmann I, Falk W et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily; sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-10715.
55. Watanabe-Fukunaga R, Brannan CI, Itoh N et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992;148:1274-1279.
56. Suda T, Takahashi T, Golstein P et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
57. Quirk SM, Cowan RG, Joshi SG et al. Fas antigen-mediated apoptosis in human granulosa/luteal cells. Biol Reprod 1995; 52:279-287.
58. Cataldo NA, Jaffe RB. Human luteinizing granulosa cells express APO-1/Fas, and interferon gamma increases their susceptibility to anti-APO-1-mediated apoptosis. Society for Gynecologic Investigation 43rd Annual Meeting, Abstract 25, 1996.
59. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627.
60. Juengel JL, Garverick HA, Johnson AL et al. Apoptosis during luteal regression in cattle. Endocrinology 1993;132:249-254.
61. Zheng J, Fricke PM, Reynolds LP et al. Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. Biol Reprod 1994;51:623-632.
62. Rueda BR, Wegner JA, Marion SL et al. Internucleosomal DNA fragmentation in ovine luteal tissue associated with luteolysis: In vivo and in vitro analyses. Biol Reprod 1995;52: 305-312.
63. Nicosia SV, Diaz J, Nicosia RF et al. Cell proliferation and apoptosis during development and aging of the rabbit corpus luteum. Ann Clin Lab Sci 1995;25:143-157.
64. Fraser HM, Lunn SF, Young FM et al. Apoptosis and necrosis after induced luteal regression in the primate. Society for the Study of Reproduction Annual Meeting, Abstract 383, 1995.
65. Piquette GN, Tilly JL, Prichard LE et al. Detection of apoptosis in human and rat ovarian follicles. J Soc Gynecol Invest 1994;1:297-301.
66. Brännström M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993;8:1762-1775.
67. Bennegard B, Hahlin M, Wennberg E et al. Local luteolytic effect of prostaglandin F2α in the human corpus luteum. Fertil Steril 1991;56:1070-1076.
68. Lei ZM, Chegini N, Rao ChV. Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod 1991;44:1148-1156.
69. Petrovská M, Sedlák R, Nouza K et al. Development and distribution of the white blood cells within various structures of the human menstrual corpus luteum examined using an image analysis system. Am J Reprod Immunol 1992;28:77-80.
70. Brannstrom M, Pascoe V, Norman RJ et al. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril 1994;61: 488-495.
71. Fukuoka M, Yasuda K, Fujiwara H et al. Interactions between interferon gamma, tumor necrosis factor alpha, and interleukin-1 in modulating progesterone and estradiol production by human luteinized granulosa cells in culture. Human Reprod 1992;7:1361-1364.
72. Xiao S, Fundlay JK. Modulation of differentiation of rat granulosa cells in vitro by interferon-gamma. J Endocrinol 1992; 133:131-139.
73. Fairchild DL, Pate JL. Modulation of bovine luteal cell synthetic capacity by interferon-gamma. Biol Reprod 1991;44: 357-363.
74. Terranova PF, Hunter VD, Roby KF et al. Tumor necrosis factor-alpha in the female reproductive tract. Proc Soc Exp Biol Med 1995;209:325-342.
75. Mukku V, Stancel G. Regulation of epidermal growth factor receptor by estrogen. J Biol Chem 1985;260:9820-9824.
76. Gardner R. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem Mol Biol 1989;32:339-343.
77. Nelson K, Takahashi T, Bossert N et al. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 1991;88:21-25.
78. LeBrun D, Warnke R, Cleary M. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142:743-753.
79. Compel A, Sabourin J, Martin A et al. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 1994;144:1195-1202.
80. Brenner R, Slayden O. Estrogen action in the endometrium and oviduct of rhesus monkeys during RU 486 treatment. Hum Reprod 1994;9:82-97.
81. Beier H, Hegele-Hartung C, Mootz U et al. Modification of endometrial cell biology using progesterone antagonists to manipulate the implantation window. Hum Reprod 1994; 9(Suppl 1):98-115.
82. Gu Y, Jow G, Moulton B et al. Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994;135: 1272-1279.
83. Abrahamson P, Zorn T. Implantation and decidualization in rodents. J Exp Zool 1993;266:603-628.
84. Moulton B. Transforming growth factor-beta stimulates endometrial stromal apoptosis in vitro. Endocrinology 1994; 134:1055-1060.
85. Nathan B, Anbazhagan R, Clarkson P et al. Expression of bCL-2 in the developing infant breast. Histopathology 1994; 24:73-76.
86. Sabourin J, Martin A, Baruch J et al. Bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 1994;59:1-6.
87. Senie R, Kinne D. Menstrual timing of treatment for breast cancer. Monogr Natl Cancer Inst 1994:85-90.
88. Perdikaris A, Dimopoulos D, Tzingounis V. The effect of gestanone and ethynyl estradiol on benign breast disease. Clin Exp Obstet Gynecol 1995;22:28-31.
89. 2+-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochim Biophys Acta 1995;1266:135-142.
90. Fan S, Smith M, Rivet DJ 2nd et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 1995;55:1649-1654.
91. Kyprianou N, English H, Davidson N et al. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991;51:162-166.
92. Kyprianou N, Isaacs J. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989;3: 1515-1522.
93. Rotello R, Lieberman R, Purchio A et al. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 1991;88:3412-3415.
94. Kent P, O'Donoghue J, O'Hanlon D et al. Linkage analysis and the susceptibility gene (BRCA-1) in familial breast cancer. Eur J Surg Oncol 1995;21:240-241.
95. Geier A, Beery R, Haimsohn M et al. Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin. In Vitro Cell Develop Biol 1994;30A:867-874.
96. Krajewski S, Krajewska M, Shabaik A et al. Immunohistochemical determination of in vivo distribution of BAX, a dominant inhibitor of Bcl-2. Am J Pathol 1994;145:1323-1336.
97. Bargou R, Daniel P, Mapara M et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995;60:854-859.
98. Sierra A, Lloveras B, Castellsague X et al. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 1995;60:54-60.
99. Doglioni C, Dei Tos A, Laurino L et al. The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Archiv 1994;424:47-51.
100. Gee J, Robertson J, Ellis I et al. Immunocytochemical localization of bCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 1994;59:619-628.
101. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-1198.
102. Staunton M, Gaffney E. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 1995;103:300-307.
103. Lipponen P, Aaltomaa S, Kosma V et al. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994;30A:2068-2073.